Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.765
-0.045 (-1.60%)
Jun 5, 2026, 5:35 PM CET
Atrys Health Market Cap
Atrys Health has a market cap or net worth of €209.88 million as of June 5, 2026. Its market cap has increased by 2.77% in one year.
Market Cap
209.88M
Enterprise Value
454.26M
Revenue
144.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.77
Market Cap Chart
Since July 22, 2016, Atrys Health's market cap has increased from 17.85M to 209.88M, an increase of 1,076.13%. That is a compound annual growth rate of 28.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 209.88M | -5.59% |
| Dec 31, 2025 | 222.31M | -13.13% |
| Dec 31, 2024 | 255.91M | -8.07% |
| Dec 29, 2023 | 278.37M | -39.03% |
| Dec 30, 2022 | 456.55M | -26.48% |
| Dec 30, 2021 | 620.95M | 107.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.45B |
| Laboratorios Farmaceuticos Rovi | 2.94B |
| Almirall | 2.40B |
| Pharma Mar | 1.64B |
| Clínica Baviera | 919.46M |
| Oryzon Genomics | 234.86M |
| Prim, S.A. | 225.43M |
| Laboratorio Reig Jofre | 219.81M |